Clinical trial
Chemotherapy in Treating Patients With Breast Cancer
NCT00012129 · NYU Langone Health, Other · Completed
Key facts
| NCT number | NCT00012129 |
|---|---|
| Title | Chemotherapy in Treating Patients With Breast Cancer |
| Official title | Phase I/II Clinical and Pharmacological Study of Liposomal Annamycin in Anthracycline-Resistant Breast Cancer |
| Lead sponsor | NYU Langone Health, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | liposomal annamycin |
| Start date | Sep 1, 1998 |
| Primary completion | May 1, 2001 |
| First posted | Apr 20, 2004 |
| Last update posted | Mar 11, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: